Examining how covered entities utilize the 340B drug pricing program : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, October 11, 2017.
(Book)
HD9666.4 .U64 2019a
1 available
Description
Also in this Series
Copies
| Location | Call Number | Status |
|---|---|---|
| General Shelving - 3rd Floor | HD9666.4 .U64 2019a | On Shelf |
Subjects
More Details
Notes
Citations
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. (2019). Examining how covered entities utilize the 340B drug pricing program: hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, October 11, 2017 . U.S. Government Publishing Office.
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. 2019. Examining How Covered Entities Utilize the 340B Drug Pricing Program: Hearing Before the Subcommittee On Oversight and Investigations of the Committee On Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, First Session, October 11, 2017. Washington: U.S. Government Publishing Office.
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. Examining How Covered Entities Utilize the 340B Drug Pricing Program: Hearing Before the Subcommittee On Oversight and Investigations of the Committee On Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, First Session, October 11, 2017 Washington: U.S. Government Publishing Office, 2019.
Harvard Citation (style guide)United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. (2019). Examining how covered entities utilize the 340b drug pricing program: hearing before the subcommittee on oversight and investigations of the committee on energy and commerce, house of representatives, one hundred fifteenth congress, first session, october 11, 2017. Washington: U.S. Government Publishing Office.
MLA Citation, 9th Edition (style guide)United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. Examining How Covered Entities Utilize the 340B Drug Pricing Program: Hearing Before the Subcommittee On Oversight and Investigations of the Committee On Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, First Session, October 11, 2017 U.S. Government Publishing Office, 2019.